Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin versus placebo for delirium in intensive care unit patients
IRCT20240429061595N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of melatonin in delirium (2 arms), sponsored by Islamic Azad University. Primary endpoint: Delirium. Started Jan 2023; status: completed.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20240429061595N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240429061595N1.